Kerrisdale believes that Prothena's lead drug NEOD001 will fail in its current Phase 2b and Phase 3 trials. Source: BioSpace

Exonics Therapeutics closed on a $40M Series A financing which was led by The Column Group. Source: BioSpace

The hearing will focus on the therapeutic potential and ethical issues of using CRISPR technology to alter human DNA. Source: BioSpace

People diagnosed with the rare blood disorder known as Erdheim-Chester disease have a new treatment option. Source: BioSpace

The jobs are being cut because Roche is moving Swiss packaging ops to CMO-divested sites. Source: BioSpace

Shares of Haemonetics are up nearly 10 percent this morning after the company announced it was cutting about 11 percent of its workforce in a restructuring effort. Source: BioSpace

With worldwide spending on prescription drugs increasing from an estimated $774B in 2017 to over $1 trillion in 2022, a rising tide of pharmaceutical sales is lifting a lot of…

Salaries and total compensation can range from $300,000 to $500,000 per year for these employees – whether they have a Ph.D. or are just out of college. Source: BioSpace

Approval is based on Phase III results that showed Alecensa extended the average time that people lived without their disease worsening compared to crizotinib. Source: BioSpace

Harris fired the first shots on Monday. Source: BioSpace